CEPI awards Chikungunya vaccine "BBV87" $14.1 million

Vaccines |  News | 0 Comment | 03 Jun, 2020

The Coalition for Epidemic Preparedness Innovations (CEPI) on 3 June 2020 announced a new partnering agreement to advanc...Read more

Chikungunya Vaccine Candidate 'VLA1553' set to enter Phase 3 Study

Vaccines |  News | 0 Comment | 02 Jun, 2020

Chikungunya is considered to be a major public health threat by the World Health Organization. A speciality vaccine...Read more

Moderna Advances in Platform Science and Innovative Vaccine Research

Vaccines |  News | 0 Comment | 02 Jun, 2020

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to creat...Read more

Moderna finalizing protocol for Ph 3 study of COVID-19 vaccine

Vaccines |  News | 0 Comment | 04 Jun, 2020

US based Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...Read more

Intravacc, EpiVax to develop novel COVID-19 vaccine

Vaccines |  News | 0 Comment | 03 Jun, 2020

The Netherlands-based Intravacc, one of the world's leading translational research and development vaccine ins...Read more

IAVI, Merck to develop vaccine against SARS-CoV-2

Vaccines |  News | 0 Comment | 29 May, 2020

Merck, known as MSD outside the United States and Canada, and IAVI, a nonprofit scientific research organization dedicat...Read more

Novavax begins Ph 1/2 trial of COVID-19 vaccine

Vaccines |  News | 0 Comment | 28 May, 2020

US based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious di...Read more

Vaxine announces COVID-19 vaccine collaboration with Medytox

Vaccines |  News | 0 Comment | 27 May, 2020

Vaxine Pty Ltd., Adelaide, Australia announced that it has entered into a formal collaboration with Medytox Inc., a Kore...Read more

PharmaJet, Abnova to use needle-free injection technology for COVID-19 vaccine

Vaccines |  News | 0 Comment | 25 May, 2020

US based PharmaJet®, the maker of innovative, needle-free injection technology, has announced that its Needle-free I...Read more

Sinovac secures $15 M for COVID-19 vaccine development

Vaccines |  News | 0 Comment | 25 May, 2020

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, has announced a transaction in which Ad...Read more

AGC Biologics partners with Takara Bio in COVID-19 fight

Vaccines |  News | 0 Comment | 22 May, 2020

Denmark headquartered AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmace...Read more

Moderna's COVID-19 vaccine shows positive interim Ph 1 results

Vaccines |  News | 0 Comment | 20 May, 2020

US based Moderna, Inc., a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...Read more

Japan to design personalized cancer vaccine

Vaccines |  News | 0 Comment | 15 May, 2020

Transgene, a biotech company in Tokyo that designs and develops virus-based immunotherapies for the treatment of cancer,...Read more

Moderna's COVID-19 vaccine enters Ph 2 trial

Vaccines |  News | 0 Comment | 14 May, 2020

US based Moderna, Inc., a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...Read more

Pfizer, BioNTech initiate human trials with COVID-19 mRNA Vaccine

Vaccines |  News | 0 Comment | 07 May, 2020

Pfizer Inc. and BioNTech SE  announced on 5 May 2020 that the first participants have been dosed in the U.S. in the...Read more

CEPI invests $3.5M in Clover Australia for COVID-19 vaccine

Vaccines |  News | 0 Comment | 01 May, 2020

Norway based CEPI, the Coalition for Epidemic Preparedness Innovations has announced a ninth worldwide collaboration to ...Read more

NanoPass joins pharma partners for COVID-19 vaccine development

Vaccines |  News | 0 Comment | 27 Apr, 2020

Novel Coronavirus presents a global pandemic with unprecedented medical, economic and social scales. Since there is curr...Read more

CanSino Bio enrols for Ph 2 trial of COVID-19 vaccine

Vaccines |  News | 0 Comment | 27 Apr, 2020

China’s CanSino Biologics advancing its SARS-CoV-2 vaccine to a Phase II clinical trial making this vaccine c...Read more